Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis

Update Il y a 4 ans
Reference: NCT02537600

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine wether cobimetinib + vemurafenib combination treatment is effective in the treatment of BRAFV600-mutated melanoma patients with brain metastasis


Inclusion criteria

  • Malignant Melanoma

Links